Meta-analysis of TP53 mutation status in CRC patients showed that around 29% of patients had a type of TP53 mutation connected with transcriptional inactivity, with patients that had tumours with vascular and lymphatic invasion showing higher frequencies of inactivating TP53 mutations [51]. Here, TP53 is linked to colorectal carcinoma.